HEALTH

Walgreens: Flu disrupted vacation plans for 11 million Americans in 2012

BY Michael Johnsen

DEERFIELD, Ill. — More than 11 million Americans had vacation plans disrupted by the flu in 2012, according to Walgreens’ recent Impact Survey, the company announced Tuesday.   

"It is important to remember that the vaccine doesn’t just protect the person getting a flu shot, it helps to protect friends, family, co-workers and others with whom they’re coming in contact," said Harry Leider, Walgreens chief medical officer. "This time of year, germs and viruses can easily spread as people travel, gather for the holidays and enjoy other seasonal community activities. Last year we saw the widespread effect this can have for those who maybe didn’t take the proper preventive measures." 

The Walgreens Flu Impact Report found that last year’s severe flu season significantly impacted holiday events in general, with 17 million of them cancelled or interrupted, based on survey projections. The 2012-2013 flu season was one of the most severe in the United States in more than a decade and, according to the study, had three times the impact than a more typical flu season on travel and holiday plans.

The Flu Impact Survey was conducted online within the United States by USamp on behalf of Walgreens from Aug. 27 to Sept. 4, 2013, among 1,200 nationally representative adults ages 18 years and older.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Absorption Pharmaceuticals to conduct clinical trials of Promescent with Kaiser

BY Michael Johnsen

NEW YORK — Absorption Pharmaceuticals will be conducting clinical trials with Kaiser to measure the efficacy of the company’s over-the-counter solution for PE Promescent, CNBC reported Tuesday. 

Beginning next week, Kaiser will follow 150 men who suffer from premature ejaculation and will be given either Promescent or a placebo over the course of the next year. Patients are being recruited from the San Diego and Los Angeles markets, according to the report.  

Absorption has also released a new commercial in support of Promescent. 

keyboard_arrow_downCOMMENTS

Leave a Reply

T.Peters says:
Dec-10-2013 05:24 pm

I have been following Promescent since they had an article come out last October on CNBC. The product was developed by Urologists and is rapidly becoming the treatment embraced by the medical community. It has an absorption technology that penetrates the top layer of skin and desensitizes the nerves in the penis. Promescent has no transference to your partner, allows the men retain sensation, is safe and easy to use. Promescent seems to offers a legitimate medical solution to those with PE or to those who would just like to prolong the experience. Wish I had developed this product, so much potential. Here is a link to the old CNBC article as well as another one that came out this morning. http://www.cnbc.com/id/101084377 http://www.cnbc.com/id/101260806

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Lancet review: Vitamin D marker for deteriorating health

BY Michael Johnsen

PHILADELPHIA — A review published in the Lancet Diabetes & Endrocrinology last week determined that low vitamin D levels are not a cause but a consequence of ill health. 

"If the health benefits of high vitamin D concentrations shown by data from observational studies are not reproduced in randomized trials … then the relation between vitamin D status and disorders are probably the result of confounding or physiological events involved in these disorders," stated lead author Professor Philippe Autier from the International Prevention Research Institute in Lyon, France.

They found that the benefits of high vitamin D concentrations from observational studies — including reduced risk of cardiovascular events (up to 58%), diabetes (up to 38%), and colorectal cancer (up to 34%) — were not confirmed in randomized trials. According to Autier, "What this discrepancy suggests is that decreases in vitamin D levels are a marker of deteriorating health. Ageing and inflammatory processes involved in disease occurrence and clinical course reduce vitamin D concentrations, which would explain why vitamin D deficiency is reported in a wide range of disorders."

"This systematic review is important because it addresses the fact that when people get seriously ill, they often experience nutrient depletions, including low vitamin D levels," Duffy MacKay, VP scientific and regulatory affairs for the Council for Responsible Nutrition said. "When this happens, dietary supplementation should be discussed by the patient and a team of healthcare practitioners because vitamin D is not easily obtained through food, and getting it through sunlight can pose risks—making supplementation a viable option," he said. 

"It may be unrealistic to expect vitamin D in isolation from other healthy habits to prevent a disease such as cancer or cardiovascular disease," MacKay noted. "But we know that one component of disease prevention involves a healthy diet, of which vitamin D is a vital part.”

Autier and colleagues analyzed data from 290 prospective observational studies and 172 randomized trials examining the effects of vitamin D levels on non-bone health outcomes up to December 2012.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?